As shown in Figure 1A, leptin treatment significantly promoted the growth of MCF-7 breast cancer cells in a dose-dependent manner, whereas no significant growth effect was observed in MDA-MB-231 cells (Figure 1B), which are ER negative breast cancer cells. Here, LEP is linked to breast carcinoma.